BII’s women’s health initiative aims to strengthen the European ecosystem for innovative translational research and start-ups that address the high medical unmet needs within women’s health.
Part of women’s health initiative activities are supported by a grant from Bill & Melinda Gates Foundation.
As part of this joint initiative, BII will conduct a thorough landscape analysis and identify leading research and start-up opportunities for women’s health, with the potential for future funding from BII and partners.
BII will also undertake community building and awareness creating activities with selected key partners within the ecosystem.
Please contact Johanna Roostalu at e-mail: email@example.com if you have any questions.
The BioInnovation Institute Foundation (BII) is an international commercial foundation with a nonprofit objective supported by the Novo Nordisk Founda-tion. BII operates an incubator to accelerate world-class life science innovation that drives the development of new solutions by early life science start-ups for the benefit of people and society.
BII, located in Copenhagen, Denmark, offers start-ups and early-stage projects within health tech, therapeutics, and bio-industrials state-of-the-art labs, vibrant office facilities, business development, start-up business incubation, access to high-level mentoring and international networks, plus unique funding opportuni-ties of up to 1.3 million euro per start-up and 2.4 million euro per project.
Since the inauguration of BII in November 2018, BII has awarded 44 million euros to 79 high-growth start-up companies.